INS and Hypoglycemia: Despite this, there may be an increased risk of hypoglycemia when combining basal insulin with sulfonylurea; both agents are associated with hypoglycemic events, albeit that newer sulfonylureas (glipizide, glimepiride, and gliclazide) may carry a lower risk [22].